Ryan Specialty Net Worth
Ryan Specialty Net Worth Breakdown | RYAN |
Ryan Specialty Net Worth Analysis
Ryan Specialty's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Ryan Specialty's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Ryan Specialty's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Ryan Specialty's net worth analysis. One common approach is to calculate Ryan Specialty's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Ryan Specialty's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Ryan Specialty's net worth. This approach calculates the present value of Ryan Specialty's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Ryan Specialty's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Ryan Specialty's net worth. This involves comparing Ryan Specialty's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Ryan Specialty's net worth relative to its peers.
Enterprise Value |
|
To determine if Ryan Specialty is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Ryan Specialty's net worth research are outlined below:
| Ryan Specialty Group has a poor financial position based on the latest SEC disclosures | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0328 subject to Rule 16b-3 |
Ryan Specialty Quarterly Good Will |
|
Ryan Specialty uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Ryan Specialty Group. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ryan Specialty's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Ryan Specialty Target Price Consensus
Ryan target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Ryan Specialty's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Buy |
Most Ryan analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Ryan stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Ryan Specialty Group, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationRyan Specialty Target Price Projection
Ryan Specialty's current and average target prices are 66.61 and 74.80, respectively. The current price of Ryan Specialty is the price at which Ryan Specialty Group is currently trading. On the other hand, Ryan Specialty's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Ryan Specialty Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Ryan Specialty Target Price
Know Ryan Specialty's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ryan Specialty is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ryan Specialty Group backward and forwards among themselves. Ryan Specialty's institutional investor refers to the entity that pools money to purchase Ryan Specialty's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.8 M | Barclays Plc | 2024-09-30 | 1.6 M | Stephens Inv Mgmt Group Llc | 2024-09-30 | 1.6 M | Polar Capital Holdings Plc | 2024-09-30 | 1.5 M | Alliancebernstein L.p. | 2024-09-30 | 1.5 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.4 M | Eagle Asset Management, Inc. | 2024-09-30 | 1.4 M | Sumitomo Mitsui Trust Group Inc | 2024-09-30 | 1.2 M | American Century Companies Inc | 2024-09-30 | 1.1 M | Vanguard Group Inc | 2024-09-30 | 9.4 M | Blackrock Inc | 2024-09-30 | 9.3 M |
Follow Ryan Specialty's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 17.14 B.Market Cap |
|
Project Ryan Specialty's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.09 | 0.10 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.10 | 0.12 |
When accessing Ryan Specialty's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Ryan Specialty's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Ryan Specialty's profitability and make more informed investment decisions.
Evaluate Ryan Specialty's management efficiency
Ryan Specialty Group has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2407 %, meaning that it created $0.2407 on every $100 dollars invested by stockholders. Ryan Specialty's management efficiency ratios could be used to measure how well Ryan Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ryan Specialty's Return On Capital Employed is very stable compared to the past year. As of the 30th of January 2025, Return On Equity is likely to grow to 0.12, while Return On Tangible Assets are likely to drop 0.01. At this time, Ryan Specialty's Net Tangible Assets are very stable compared to the past year. As of the 30th of January 2025, Non Currrent Assets Other is likely to grow to about 65.7 M, while Total Assets are likely to drop about 5.7 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 7.71 | 8.10 | |
| Tangible Book Value Per Share | (12.85) | (13.49) | |
| Enterprise Value Over EBITDA | 14.41 | 21.43 | |
| Price Book Value Ratio | 7.91 | 5.40 | |
| Enterprise Value Multiple | 14.41 | 21.43 | |
| Price Fair Value | 7.91 | 5.40 | |
| Enterprise Value | 5.6 B | 4.7 B |
Evaluating the management effectiveness of Ryan Specialty allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Ryan Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 4.5317 | Revenue | Quarterly Revenue Growth 0.207 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ryan Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ryan Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ryan Specialty insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ryan Specialty Corporate Filings
F4 | 28th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 9th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Ryan Specialty Earnings Estimation Breakdown
The calculation of Ryan Specialty's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Ryan Specialty is estimated to be 0.45 with the future projection ranging from a low of 0.4425 to a high of 0.4625. Please be aware that this consensus of annual earnings estimates for Ryan Specialty Group is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.44 Lowest | Expected EPS | 0.46 Highest |
Ryan Specialty Earnings Projection Consensus
Suppose the current estimates of Ryan Specialty's value are higher than the current market price of the Ryan Specialty stock. In this case, investors may conclude that Ryan Specialty is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Ryan Specialty's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 14 | 96.41% | 0.41 | 0.45 | 0.77 |
Ryan Specialty Earnings per Share Projection vs Actual
Actual Earning per Share of Ryan Specialty refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Ryan Specialty Group predict the company's earnings will be in the future. The higher the earnings per share of Ryan Specialty, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Ryan Specialty Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Ryan Specialty, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Ryan Specialty should always be considered in relation to other companies to make a more educated investment decision.Ryan Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Ryan Specialty's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-30 | 2024-09-30 | 0.42 | 0.41 | -0.01 | 2 | ||
2024-08-01 | 2024-06-30 | 0.56 | 0.58 | 0.02 | 3 | ||
2024-05-02 | 2024-03-31 | 0.35 | 0.35 | 0.0 | 0 | ||
2024-02-27 | 2023-12-31 | 0.34 | 0.35 | 0.01 | 2 | ||
2023-11-02 | 2023-09-30 | 0.31 | 0.32 | 0.01 | 3 | ||
2023-08-03 | 2023-06-30 | 0.44 | 0.45 | 0.01 | 2 | ||
2023-05-04 | 2023-03-31 | 0.25 | 0.26 | 0.01 | 4 | ||
2023-02-28 | 2022-12-31 | 0.26 | 0.27 | 0.01 | 3 | ||
2022-11-10 | 2022-09-30 | 0.26 | 0.25 | -0.01 | 3 | ||
2022-08-11 | 2022-06-30 | 0.35 | 0.39 | 0.04 | 11 | ||
2022-05-12 | 2022-03-31 | 0.22 | 0.24 | 0.02 | 9 | ||
2022-03-15 | 2021-12-31 | 0.28 | 0.29 | 0.01 | 3 | ||
2021-11-11 | 2021-09-30 | 0.18 | 0.24 | 0.06 | 33 | ||
2021-09-01 | 2021-06-30 | 0.32 | 0.35 | 0.03 | 9 | ||
2021-06-02 | 2021-03-31 | 0 | 0.21 | 0.21 | 0 |
Ryan Specialty Corporate Management
| Mark Esq | General VP | Profile | |
| Alice Topping | Chief Officer | Profile | |
| Brendan Mulshine | Executive Vice President Chief Revenue Officer | Profile | |
| Kirk Behrens | Technology Operations | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.408 | Dividend Share 0.33 | Earnings Share 0.77 | Revenue Per Share | Quarterly Revenue Growth 0.207 |
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ryan Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.